| JPM PACIFIC EQUITY I (ACC) USD | RVI ASIA | 15,76% | · | · | 1.087,15% |
| JPM EUROPE STRATEGIC GROWTH I (ACC) EUR | RVI EUROPA CRECIMIENTO | 14,55% | · | · | 773,51% |
| CANDRIAM EQUITIES L BIOTECHNOLOGY C CAP | BIOTECNOLOGÍA | 10,68% | 38,73% | 163,62% | 438,39% |
| CANDRIAM EQUITIES L BIOTECHNOLOGY D DIS | BIOTECNOLOGÍA | 10,04% | 35,36% | 155,89% | 420,82% |
| CANDRIAM EQUITIES L BIOTECHNOLOGY N CAP | BIOTECNOLOGÍA | 10,17% | 36,78% | 157,59% | 414,23% |
| FRANKLIN BIOTECHNOLOGY DISCOVERY I (ACC) USD | BIOTECNOLOGÍA | 5,86% | 28,55% | 149,16% | 367,17% |
| UBS (LUX) EQUITY FUND - BIOTECH (USD) P-ACC | BIOTECNOLOGÍA | 10,73% | 32,48% | 147,18% | 352,55% |
| CREDIT SUISSE (LUX) GLOBAL BIOTECH INNOVATORS EQUITY IB USD | BIOTECNOLOGÍA | 10,86% | 40,08% | 160,79% | 335,53% |
| FRANKLIN BIOTECHNOLOGY DISCOVERY A (ACC) USD | BIOTECNOLOGÍA | 4,97% | 25,31% | 138,83% | 326,45% |
| DWS BIOTECH | BIOTECNOLOGÍA | 10,16% | 30,22% | 136,13% | 301,86% |
| FRANKLIN BIOTECHNOLOGY DISCOVERY N (ACC) USD | BIOTECNOLOGÍA | 4,22% | 22,54% | 130,05% | 295,78% |
| JANUS GLOBAL LIFE SCIENCES I USD CAP | BIOTECNOLOGÍA | 2,52% | 32,38% | 151,60% | 258,41% |
| HENDERSON HF - JAPANESE SMALLER COMPANIES I2 USD | RVI JAPÓN SMALL/MID CAP | 11,18% | 74,34% | 159,72% | 250,53% |
| M&G JAPAN SMALLER COMPANIES FUND EUR C ACC | RVI JAPÓN SMALL/MID CAP | 17,36% | 61,92% | 155,20% | 249,22% |
| BLACKROCK EUROPEAN OPPORTUNITIES EXTENSION A2 EUR | RVI EUROPA | 17,44% | 73,30% | 194,11% | 246,12% |
| LYXOR NASDAQ-100 UCITS ETF D EUR | RVI USA | 14,22% | 53,94% | 120,75% | 238,20% |
| HENDERSON HF - JAPANESE SMALLER COMPANIES A2 USD | RVI JAPÓN SMALL/MID CAP | 10,36% | 71,08% | 153,82% | 230,41% |
| JANUS GLOBAL LIFE SCIENCES A USD CAP | BIOTECNOLOGÍA | 1,76% | 29,42% | 141,75% | 228,32% |
| M&G JAPAN SMALLER COMPANIES FUND EUR A ACC | RVI JAPÓN SMALL/MID CAP | 16,48% | 58,32% | 145,81% | 224,02% |
| CREDIT SUISSE (LUX) GLOBAL BIOTECH INNOVATORS EQUITY BH EUR | BIOTECNOLOGÍA | 15,33% | 22,56% | 118,46% | 219,87% |
